Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model
Abstract
Authors
KA Kelton JC Gahn RW Klein S Ramachandran Y Asukai
KA Kelton JC Gahn RW Klein S Ramachandran Y Asukai
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now